Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Other financing activities (2018 - 2019)

Historic Other financing activities for Revolution Medicines (RVMD) over the last 2 years, with Q4 2019 value amounting to $4.7 million.

  • Revolution Medicines' Other financing activities rose 26446.15% to $4.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.7 million, marking a year-over-year increase of 26446.15%. This contributed to the annual value of $4.7 million for FY2019, which is 26446.15% up from last year.
  • According to the latest figures from Q4 2019, Revolution Medicines' Other financing activities is $4.7 million, which was up 26446.15% from $1.3 million recorded in Q4 2018.
  • Revolution Medicines' 5-year Other financing activities high stood at $4.7 million for Q4 2019, and its period low was $1.3 million during Q4 2018.